Expert consensus on the systemic treatment of atopic dermatitis in special populations
Adam, D. N., Gooderham, M. J., Beecker, J. R., Hong, C. H., Jack, C. S., Jain, V., Lansang, P., Lynde, C. W., Papp, K. A., Prajapati, V. H., Turchin, I., Yeung, J.
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2023)
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2023)
Get full text
Journal Article
Flagellate purpura associated with COVID‐19 vaccination
Heck, E., Rankin, B.D., Schneider, M., Prajapati, V.H.
Published in Journal of the European Academy of Dermatology and Venereology (01.01.2022)
Published in Journal of the European Academy of Dermatology and Venereology (01.01.2022)
Get full text
Journal Article
Incidence and prognosis of COVID‐19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study
Georgakopoulos, J.R., Mufti, A., Vender, R., Prajapati, V.H., Yeung, J.
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2021)
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2021)
Get full text
Journal Article
Cross‐sectional quantitative validation of the paediatric Localized Scleroderma Quality of Life Instrument (LoSQI): A disease‐specific patient‐reported outcome measure
Zigler, C. K., Lin, L., Ardalan, K., Jacobe, H., Lane, S., Li, S. C., Luca, N. J. C., Prajapati, V. H., Schollaert, K., Teske, N., Torok, K.
Published in Journal of the European Academy of Dermatology and Venereology (01.07.2023)
Published in Journal of the European Academy of Dermatology and Venereology (01.07.2023)
Get full text
Journal Article
Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study
Lytvyn, Y., Georgakopoulos, J.R., Mufti, A., Devani, A.R., Gooderham, M.J., Jain, V., Lansang, P., Vender, R., Prajapati, V.H., Yeung, J.
Published in Journal of the European Academy of Dermatology and Venereology (01.02.2022)
Published in Journal of the European Academy of Dermatology and Venereology (01.02.2022)
Get full text
Journal Article
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
Blauvelt, Andrew, Teixeira, Henrique D, Simpson, Eric L, Costanzo, Antonio, De Bruin-Weller, Marjolein, Barbarot, Sebastien, Prajapati, Vimal H, Lio, Peter, Hu, Xiaofei, Wu, Tianshuang, Liu, John, Ladizinski, Barry, Chu, Alvina D, Eyerich, Kilian
Published in JAMA dermatology (Chicago, Ill.) (01.09.2021)
Published in JAMA dermatology (Chicago, Ill.) (01.09.2021)
Get more information
Journal Article
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
Blauvelt, Andrew, Ladizinski, Barry, Prajapati, Vimal H., Laquer, Vivian, Fischer, Alison, Eisman, Samantha, Hu, Xiaofei, Wu, Tianshuang, Calimlim, Brian M., Kaplan, Blair, Liu, Yingyi, Teixeira, Henrique D., Liu, John, Eyerich, Kilian
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up)
Simpson, EL, Costanzo, A, Prajapati, VH, Calimlim, BM, Chu, AD, Wu, TS, Eyerich, K
Published in BRITISH JOURNAL OF DERMATOLOGY (2024)
Published in BRITISH JOURNAL OF DERMATOLOGY (2024)
Get full text
Conference Proceeding
Efficacy and safety of switching from dupilumab to upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension trial
Blauvelt, A, Ladizinski, B, Prajapati, VH, Laquer, V, Fischer, A, Eisman, S, Wu, T, Vigna, N, Teixeira, HD, Liu, J, Eyerich, K
Published in BRITISH JOURNAL OF DERMATOLOGY (2022)
Get full text
Published in BRITISH JOURNAL OF DERMATOLOGY (2022)
Conference Proceeding
Upadacitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the Heads Up phase III trial
Blauvelt, A, Teixeira, HD, Simpson, EL, Costanzo, A, De Bruin-Weller, M, Barbarot, S, Prajapati, VH, Lio, P, Hu, X, Wu, T, Liu, J, Ladizinski, B, Chu, AD, Eyerich, K
Published in BRITISH JOURNAL OF DERMATOLOGY (2021)
Get full text
Published in BRITISH JOURNAL OF DERMATOLOGY (2021)
Conference Proceeding
UPADACITINIB VERSUS DUPILUMAB IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF THE HEADS UP PHASE 3 TRIAL
Blauvelt, A, Teixeira, HD, Simpson, EL, Costanzo, A, De Bruin-Weller, M, Barbarot, S, Prajapati, VH, Lio, P, Hu, XF, Wu, TS, Liu, J, Ladizinski, B, Chu, AD, Eyerich, K
Published in ACTA DERMATO-VENEREOLOGICA (2021)
Get full text
Published in ACTA DERMATO-VENEREOLOGICA (2021)
Conference Proceeding